Immunotherapy with Ag85B for Tuberculosis Treatment
Author Information
Author(s): Sheikh Javaid A, Khuller Gopal K, Verma Indu
Primary Institution: Postgraduate Institute of Medical Education and Research, Chandigarh, India
Hypothesis
Can Ag85B enhance the effectiveness of antituberculous chemotherapy in treating tuberculosis?
Conclusion
The combination of immunotherapy with Ag85B and chemotherapy shows promise in improving tuberculosis treatment outcomes.
Supporting Evidence
- Ag85B significantly reduced bacterial numbers in the spleen and lung compared to controls.
- The therapeutic effect of Ag85B was comparable to short-term chemotherapy.
- Immunotherapy with Ag85B allowed for reduced dosages of antituberculous drugs.
Takeaway
This study found that using a special protein called Ag85B along with regular tuberculosis medicine can help fight the disease better.
Methodology
Mice infected with Mycobacterium tuberculosis were treated with chemotherapy or immunotherapy, and bacterial counts were measured in lungs and spleen.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
6-8 week old female Balb/c mice
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website